Celcuity, Inc. (CELC)
104.79
-1.99
(-1.86%)
USD |
NASDAQ |
Feb 20, 16:00
104.91
+0.12
(+0.11%)
After-Hours: 20:00
Celcuity SG&A Expense (Quarterly) : 7.934M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 46.02M |
| Cidara Therapeutics, Inc. | 8.099M |
| Cogent Biosciences, Inc. | 23.93M |
| Relay Therapeutics, Inc. | 12.13M |
| Praxis Precision Medicines, Inc. | 19.54M |